0001628280-24-028072.txt : 20240613
0001628280-24-028072.hdr.sgml : 20240613
20240613162602
ACCESSION NUMBER: 0001628280-24-028072
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240612
FILED AS OF DATE: 20240613
DATE AS OF CHANGE: 20240613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schall Thomas J.
CENTRAL INDEX KEY: 0001423084
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40675
FILM NUMBER: 241041603
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immuneering Corp
CENTRAL INDEX KEY: 0001790340
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 MAIN STREET, SECOND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-500-8080
MAIL ADDRESS:
STREET 1: 245 MAIN STREET, SECOND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
wk-form4_1718310353.xml
FORM 4
X0508
4
2024-06-12
0
0001790340
Immuneering Corp
IMRX
0001423084
Schall Thomas J.
C/O IMMUNEERING CORPORATION
245 MAIN STREET, 2ND FLOOR
CAMBRIDGE
MA
02142
1
0
0
0
0
Stock Option
1.54
2024-06-12
4
A
0
8588
0
A
2034-06-12
Class A Common Stock
8588
8588
D
The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 12, 2024, and will be fully vested and exercisable on June 12, 2025, or the date of the 2025 annual meeting of stockholders, whichever comes first.
/s/ Michael D. Bookman, Attorney-in-Fact for Thomas J. Schall
2024-06-13